Vijaya Diagnostic Centre Ltd.
VIJAYA · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹609.86.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%19.7%
- ✓Low debt (D/E < 0.5)0.44x
- ✕Positive free cash flow
- ✓Revenue growth > 10%27%
- ✓Earnings growing38%
- ✓Net margin ≥ 10%21.2%
- ✓Current ratio > 1.52.60
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 15.77
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Strong return on equity (19.7%).
- •Healthy profit margin (21.2%).
- •Financially solid — Altman Z 15.77.
Opportunities
- •Earnings growing (38% YoY).
- •Revenue growing (27% YoY).
Threats
- •Rich valuation versus sector peers.
- •Trades ~41% above our estimated fair value.
About Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.